Li Fang-xuan, Zhang Ru-peng, Zhao Jing-zhu, Wang Gang
Department of Gastric Cancer, Cancer Institute and Hospital of Tianjin Medical University, Tianjin 300060, China.
Zhonghua Wai Ke Za Zhi. 2011 Mar 1;49(3):204-7.
To explore the clinicopathological characteristics and prognostic factors of gastric stump cancer(GSC).
The clinical data of 138 patients with GSC treated from January 1992 to July 2008 were reviewed and analyzed. The patients included 122 males and 16 females with a mean age of 61.5 years, and the mean interval between the initial operation and second diagnosis was 21.9 years.
The endoscopy and pathological examination showed Borrmann III/IV in 127 (92.7%) patients and undifferentiated carcinoma in 115 (83.3%) patients. The resectability and radical resectability rate were 72.4% and 59.4%. The 1-, 3- and 5-year survival rates was 59.2%, 30.1% and 14.2%, respectively. The median overall survival time was 19.4 months. Univariate Log-rank test indicated that Borrmann type, histological type, tumor diameter, TNM stage, depth of invasion, number of metastatic lymph node, distant metastasis and option of treatment were significant prognostic factors for GSC. While TNM stage, depth of invasion, distant metastasis and option of treatment were prognostic factors on multivariable analysis. The median survival time of patients underwent radical resection was significantly longer (36 months) than that of patients received palliative resection (8 months, P < 0.05) and chemotherapy only (5 months, P < 0.05). Among patients with a tumor of T4 stage, the median survival time was statistically prolonged by combined evisceration (18.6 months) when compared with the patients received palliative surgery.
TNM stage, depth of invasion, distant metastasis and option of treatment are independent prognostic factors for GSC. Early diagnosis and radical resection may play an important role in improving the prognosis of GSC.
探讨残胃癌(GSC)的临床病理特征及预后因素。
回顾性分析1992年1月至2008年7月收治的138例GSC患者的临床资料。患者中男性122例,女性16例,平均年龄61.5岁,初次手术至二次诊断的平均间隔时间为21.9年。
内镜及病理检查显示,127例(92.7%)患者为Borrmann III/IV型,115例(83.3%)患者为未分化癌。可切除率和根治性切除率分别为72.4%和59.4%。1年、3年和5年生存率分别为59.2%、30.1%和14.2%。中位总生存时间为19.4个月。单因素Log-rank检验表明,Borrmann分型、组织学类型、肿瘤直径、TNM分期、浸润深度、转移淋巴结数目、远处转移及治疗方式是GSC的重要预后因素。多因素分析显示,TNM分期、浸润深度、远处转移及治疗方式是预后因素。接受根治性切除患者的中位生存时间(36个月)显著长于接受姑息性切除患者(8个月,P<0.05)和单纯化疗患者(5个月,P<0.05)。在T4期肿瘤患者中,与接受姑息性手术的患者相比,联合脏器切除可使中位生存时间有统计学意义的延长(18.6个月)。
TNM分期、浸润深度、远处转移及治疗方式是GSC的独立预后因素。早期诊断和根治性切除可能对改善GSC的预后起重要作用。